Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model

por Sun, Michel M., Chan, Ann M., Law, Samuel M., Duarte, Sergio, Diaz-Aguilar, Daniel, Wadehra, Madhuri, Gordon, Lynn K.
Publicado en Invest Ophthalmol Vis Sci (2019)

EMP2 is a novel regulator of stemness in breast cancer cells

por Dillard, Christen, Kiyohara, Meagan, Mah, Vei, McDermott, Sean P., Bazzoun, Dana, Tsui, Jessica, Chan, Ann M., Haddad, Ghassan, Pellegrini, Matteo, Chang, Yu-Ling, Elshimali, Yahya, Wu, Yanyuan, Vadgama, Jaydutt V., Kim, Sara Ruth, Goodglick, Lee, Law, Samuel M., Patel, Deven D., Dhawan, Puneet, O’Brien, Neil A., Gordon, Lynn K., Braun, Jonathan, Lazar, Gary, Wicha, Max S., Wadehra, Madhuri
Publicado en Mol Cancer Ther (2020)